← All stocks

MBX Biosciences, Inc.

MBX Net buying
CIK 0001776111 #1706 in the set updated 17 Sep 2026
Bought (120 mo)
$153.68M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.73M
$0.00 on a plan · $2.69M straight out of an exercise
Sold at will
$49.09K
3 of 5 sales
Net
+$150.95M
+$153.64M against sales at will

By person

23 insiders · 38 transactions
127×

P. Kent Hawryluk holds 127 times base salary in stock. $79.87M of shares against $625.00K in salary for 2025.

Salary from the company's own proxy. The shares are what P. Kent Hawryluk last reported holding, valued at $65.77, the price Common Stock was last bought or sold at on the open market here, on 4 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Heron Patrick J
Director
$22.00M (2)
+$22.00M
5,219,440
10.84%
$343.28M
GORDON CARL L
Director
$14.02M (6)
+$14.02M
747,887
1.55%
$49.19M
ORBIMED ADVISORS LLC entity
Director
$14.02M (6)
+$14.02M
747,887
1.55%
$49.19M
Aynechi Tiba
Director
$12.00M (1)
+$12.00M
2,136,335
4.44%
$140.51M
Frazier Life Sciences X, L.P.
10% owner
$10.00M (1)
+$10.00M
4,552,774
9.45%
$299.44M
BASKETT FOREST
10% owner
$8.00M (1)
+$8.00M
3,614,486
7.51%
$237.72M
Behbahani Ali
10% owner
$8.00M (1)
+$8.00M
3,614,486
7.51%
$237.72M
Chang Carmen
10% owner
$8.00M (1)
+$8.00M
3,614,486
7.51%
$237.72M
Florence Anthony A. Jr.
10% owner
$8.00M (1)
+$8.00M
3,614,486
7.51%
$237.72M
Makhzoumi Mohamad
10% owner
$8.00M (1)
+$8.00M
3,614,486
7.51%
$237.72M
Mathers Edward T
Director
$8.00M (1)
+$8.00M
3,614,486
7.51%
$237.72M
New Enterprise Associates 17, L.P. entity
10% owner
$8.00M (1)
+$8.00M
3,614,486
7.51%
$237.72M
SANDELL SCOTT D
10% owner
$8.00M (1)
+$8.00M
3,614,486
7.51%
$237.72M
Walker Paul Edward
10% owner
$8.00M (1)
+$8.00M
3,614,486
7.51%
$237.72M
Yang Rick
10% owner
$8.00M (1)
+$8.00M
3,614,486
7.51%
$237.72M
Azoulay Salomon
Chief Medical Officer
$2.72M (4) scheduled
−$2.72M
14,399
0.0299%
$947.02K
Hawryluk P. Kent
President & CEO
$1.33M (3)
$17.93K (1)
+$1.32M
1,214,444
2.52%
$79.87M
+153.1%
Hoerter Steven L.
President and CEO
$264.98K (1)
+$264.98K
102,938
0.2137%
$6.77M
Pescovitz Ora H.
Director
$45.31K (1)
+$45.31K
24,329
0.0505%
$1.60M
+46.2%
Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
10% owner
1,790,122
3.72%
$117.74M
CORNELIUS JAMES M
Director
102,082
0.2120%
$6.71M
Smither John W
Chief Financial Officer
28,000
0.0581%
$1.84M
Bartram Richard
Chief Financial Officer
15,000
0.0311%
$986.55K
Insider
Date
Role
Action
Shares
Price
Amount
Azoulay Salomon
8 May 2026
Chief Medical Officer
Sold after exercise
15,003
$38.30
$574.61K
Azoulay Salomon
8 May 2026
Chief Medical Officer
Sold after exercise
55,000
$38.38
$2.11M

What was left out

Form 4 filings counted 68
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 49,260,955
History held since 13 Sep 2024